Prevention of heart failure

Current Opinion in Cardiology

Volumn 21, Issue 5, 2006, Pages 510-516

  Bansal, Darpan ^b   Chahoud, Georges ^a   Smith, Eugene S ^b   Mehta, Jawahar L ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

Clinical trials; Heart failure; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LISINOPRIL; LOSARTAN; PERINDOPRIL; PLACEBO; RAMIPRIL; SIMVASTATIN; TRANDOLAPRIL;

CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; CORONARY ARTERY ATHEROSCLEROSIS; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KINESIOTHERAPY; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; VALVULAR HEART DISEASE;

ATHEROSCLEROSIS; CARDIAC OUTPUT, LOW; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; DIABETES COMPLICATIONS; EPIDEMIOLOGIC STUDIES; HUMANS; HYPERTENSION; META-ANALYSIS; META-ANALYSIS AS TOPIC; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 33747033691     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000240590.99215.bb     Document Type: Review

References (48)

1. American Heart Association. Heart disease and stroke statistics 2004 update. Dallas, Texas: American Heart Association; 2003.
2. National Heart, Lung, and Blood Institute. Data fact sheet: congestive heart failure in the United States: a new epidemic. Bethesda, Maryland: US Dept of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute; 1996.
3. Braunwald E. Shattuck Lecture: cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337:1360-1369.
4. Rich MW. Heart failure in the 21st century: a cardiogeriatric syndrome. J Gerontol 2001; 56A:M88-M96.
5. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22:6A.
6. Barker WH, Mullooly JP, Getchell W. Changing incidence and survival for heart failure in a well defined older population, 1970-1974 and 1990-1994. Circulation 2006; 113:799-805. This study concluded that the epidemic increase in heart failure among the older population between the 1970s and 1990s is associated with increased incidence and improved survival, with both of these effects being greater in men.
7. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: The Rotterdam Study. Eur Heart J 2004; 25:1614-1619.
8. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106:3068-3072.
9. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348:2007-2018.
10. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodelling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000; 35:569-582.
11. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46:e1-e82.
12. Kannel WB, D'Agostino RB, Silbershatz H, et al. Profile for estimating risk of heart failure. Arch Intern Med 1999; 159:1197-1204.
13. He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001; 161:996-1002.
14. Baldasseroni S, Opasich C, Gorini M, et al. Left-bundle-branch block was associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002; 143:398-405.
15. Chen YT, Vaccarino V, Williams CS, et al. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 1999; 106:605-612.
16. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-1562.
17. Gueyffier F, Bulpitt C, Boissel JP, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet 1999; 353:793-796.
18. Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 1997; 278:212-216.
19. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342:145-153.
20. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277:739-745.
21. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
22. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72 (suppl):S3-S9.
23. Richards AM, Nicholls MG, Troughton RW, et al. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002; 39:1182-1188.
24. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease randomized, double-blind, placebo-controlled, multicenter trial (the EUROPA study). Lancet 2003; 362:782-788.
25. Braunwald E, Domanski MJ, Fowler SE, et al., PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004; 351:2058-2068.
26. Kjekshus J, Pedersen TR, Olsson AG, et al. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Cardiac Failure 1997; 3:249-254.
27. Burt A, Thornley P, Illingworth D, et al. Stopping smoking after myocardial infarction. Lancet 1974; 1:304-306.
28. Krumholz HM, Chen YT, Wang Y, et al. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 2000; 139:72-77.
29. Vaur L, Gueret P, Lievre M, et al. Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study. Diabetes Care 2003; 26:855-860.
30. The Hope Study investigators. Heart Outcomes Prevention Evaluation Study Investigators, Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-259.
31. Berl T, Hunsicker LG, Lewis JB, et al. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med 2003; 138:542-549.
32. Brenner BM, Cooper ME, De Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861-869.
33. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347:305-313.
34. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001; 321:225-236.
35. Kenchaiah S, Gaziano JM, Vasan RS. Impact of obesity on the risk of heart failure and survival after the onset of heart failure. Med Clin North Am 2004; 88:1273-1294.
36. He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001; 161:996-1002.
37. He J, Ogden LG, Bazzano LA, et al. Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med 2002; 162:1619-1624.
38. Kereiakes DJ, Willerson JT. Metabolic syndrome epidemic. Circulation 2003; 108:1552-1553.
39. Wilson PW, Grundy SM. The metabolic syndrome: practical guide to origins and treatment: part I. Circulation 2003; 108:1422-1424.
40. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91:999-1005.
41. Denoillet J, Brutsaert DL. Personality, disease severity, and the risk of long term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 1998; 97:167-173.
42. Barefoot JC, Helms MJ, Mark DB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78:613-617.
43. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993; 4:285-294.
44. Engel G. A life setting conducive to illness: the giving-up-giving-up complex. Ann Intern Med 1968; 69:293-300.
45. Califf RM, Krishnan RR, O'Connor CM. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161:1849-1856.
46. Denollet J, Brutsaert DL. Reducing emotional distress improves prognosis in coronary heart disease: 9-year mortality in a clinical trial of rehabilitation. Circulation 2001; 104:2018-2023.
47. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003; 289:3106-3116.
48. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701-709.